ePRO, E-Patient Diaries and eCOA - Global Strategic Business Report

The global market for ePRO, E-Patient Diaries and eCOA was valued at an estimated US$1.8 Billion in 2023 and is projected to reach US$4.7 Billion by 2030, growing at a CAGR of 15.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the ePRO, e-Patient Diaries, and eCOA market is driven by several factors, including technological advancements in mobile health applications and increased acceptance of telehealth practices. As smartphones and tablets become more prevalent, more patients and clinicians are able to access sophisticated health monitoring tools with ease. Regulatory bodies and health authorities are increasingly recognizing the value of real-time patient data in improving clinical outcomes, which is encouraging the adoption of these systems across global healthcare and research settings.

Additionally, the growing demand for patient-centric treatment approaches and the need for efficient data management in clinical trials are key drivers of this market. Consumer behavior towards health technology has shifted dramatically, with patients now expecting more active roles in managing their health, which aligns well with the capabilities of ePROs, e-Patient Diaries, and eCOAs. These trends, combined with the ongoing push for digital health solutions post-pandemic, underscore a dynamic expansion and evolution in the market.

Key Insights:

Market Growth: Understand the significant growth trajectory of the eClinical Outcome Assessments (eCOAs) segment, which is expected to reach US$1.4 Billion by 2030 with a CAGR of a 15.2%. The ePatient Reported Outcomes (ePROs) segment is also set to grow at 16.7% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, estimated at $629.8 Million in 2023, and China, forecasted to grow at an impressive 17.9% CAGR to reach $604.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global ePRO, E-Patient Diaries and eCOA Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global ePRO, E-Patient Diaries and eCOA Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global ePRO, E-Patient Diaries and eCOA Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Anju Software, Inc., ArisGlobal LLC, Castor EDC, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 85 Featured):

Anju Software, Inc.
ArisGlobal LLC
Castor EDC
Clario
Climedo Health GmbH
ClinCapture
Dassault Systèmes SE
eClinical Solutions LLC
ICON plc
IQVIA Holdings, Inc.
Kayentis, SAS
MedNet Solutions, Inc.
Signant Health
TransPerfect

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Pivotal Role of eCOA, ePRO and Patient Engagement in Transforming Patient Centricity
An Introduction to ePRO, E-Patient Diaries and eCOA
Influencer Market Insights
Global Economic Update
Global Market Outlook
eCOA: The Largest Category
ePRO Offers Tremendous Opportunities in Improving Healthcare System
Competition
ePRO, E-Patient Diaries and eCOA - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Digitalization of Healthcare Services and Rising Importance of Electronic Data Capture Technologies to Fuel Market Growth
Global Digital Health Market: Annual Revenues in US$ Million by Region/Country for 2020 and 2027
Patient Engagement Practices of the Future to be Shaped by Trends of Increased Use of Personal Devices and Passive Data
Key Patient Engagement Technology Trends and Innovations
eCOA & ePRO: A Powerful Duo Serving Clinical Trials with Electronic Data Collection
Rise in Clinical Trials Drives Need for ePRO, ePatient Diaries, and eCOA Solutions
Number of Registered Clinical Studies (in Thousands) Worldwide for the Period 2010-2023
Clinical Trials in the US: % Change in Trial Starts by Therapy Area for 2020 Vs 2019
Percentage Breakdown of Endpoint Adjudication Committees (EAC) Trials by Therapeutic Area: 2023E
COVID-19 Pandemic Triggers Technology Adoption in Clinical Trials
Digital Health Venture Funding in the US (in $ Billion) for the Years 2015-2023
Trends in Clinical Trials Space to Influence Market Demand
Shift towards Decentralized/Virtual Clinical Trials to Boost Market Prospects
Global Virtual Clinical Trials Market Size (in US$ Billion) for the Years 2022, 2024, 2026 and 2028
Global Virtual Clinical Trials Market by Indication (in %) for 2023E
Decentralized Clinical Trials Driving Greater Demand for Patient-Centric Drug Development
Role of eCOA & ePRO in Enhancing Data Accuracy of Decentralized Clinical Trials
Growing Volumes of Data Generation in Decentralized Trials: A Challenge
Adoption of Digital Technologies in Contract Research Organizations Bodes Well for the Market
Global Contract Research Outsourcing Market Revenues (US$ Million) by Geographic Region/Country for 2020 and 2027
Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
COVID-19 and Implications for Drug Development Regulations & Processes
Rise in Telemedicine Services Present Market Opportunities
Global Telehealth Market (In US$ Million) for Years 2022, 2024, 2026 and 2028
Growing Adoption of Mobile Technologies and BYOD Trend in Healthcare Industry Boosts Market Prospects
Smartphone Adoption Rate as a Percentage of Connections by Region for 2022 and 2030
Mobile Device Use in Healthcare Settings: % Usage by Type of Mobile Device
Electronic Patient Record (ePRO) Solutions Emerge as Ideal Replacements for Paper-Based PRO systems
Moving over Paper Pains & Mastering the Art of Real-Time Data Collection with ePRO
Delivering Better Data: A Key Benefit of ePRO
Factors Ensuring Success of ePRO Implementations
ePatient Reported Outcomes (PROs) Gain Importance in Oncology Studies
Advances in ePRO Technologies Promise Better Clinical Decision Making in Healthcare Systems
Integrating AI into ePRO Improves the Efficiency of ePRO Data Collection and Assessment
Data Integrity, Security & Privacy: Key Priorities for ePRO Solutions
Electronic Clinical Outcome Assessment Solution (eCOA) Market: Poised for Growth
Global eCOA Market Breakdown by Delivery Mode (in %) for 2023E
eCOA Usage by Clinical Trial Phase (in %) for 2021
eCOA Grants The Best Route to Improve Data Quality & Patient Experience for Clinical Trials
Benefits Offered by eCOA Systems over the Paper-Based Systems in Trials
How to Successfully Implement eCOA Systems in Clinical Trials?
New Technologies & Approaches with Potential to Augment Statistical Prowess of eCOA
Technological Trends Transforming eCOA Solutions Market
Future Trends in eCOA Market: A Review
UAT, Challenges and Embedded UAT for eCOAs
Benefits of BYOD for eCOAs
E-Patient Diaries: Significant Advantages over Paper Diaries to Drive Market
Major Benefits of ePatient Diary
eCOA & ePRO to Help Mental Health Research Shed the Taboo Status & Move Forward
Intriguing Perks of eCOA & ePRO for Mental Health Research
Increase in Healthcare Spending to Propel Demand
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Increasing Burden of Chronic Diseases and Focus on Drug Development, Therapies and Vaccines Boost Market
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
World Diabetes and Population Statistics (2019, 2030 & 2045)
Aging World Population to Drive Market Growth
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Challenges Facing Companies Implementing eCOA, ePRO & Patient-Centric Clinical Trials

4. GLOBAL MARKET PERSPECTIVE

Table 1: World ePRO, E-Patient Diaries and eCOA Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
Table 2: World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 3: World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for eClinical Outcome Assessments (eCOAs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World 7-Year Perspective for eClinical Outcome Assessments (eCOAs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 6: World Recent Past, Current & Future Analysis for ePatient Reported Outcomes (ePROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 7: World 7-Year Perspective for ePatient Reported Outcomes (ePROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 8: World Recent Past, Current & Future Analysis for Clinician Reported Outcomes (ClinROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 9: World 7-Year Perspective for Clinician Reported Outcomes (ClinROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for ePatient Diaries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World 7-Year Perspective for ePatient Diaries by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 12: World Recent Past, Current & Future Analysis for Performance Outcomes (PerfOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 13: World 7-Year Perspective for Performance Outcomes (PerfOs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 14: World Recent Past, Current & Future Analysis for Observer Reported Outcomes (ObsROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 15: World 7-Year Perspective for Observer Reported Outcomes (ObsROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for Clinical Trial Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World 7-Year Perspective for Clinical Trial Sponsors by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 18: World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 19: World 7-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 21: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 23: World 7-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 24: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 25: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 26: USA Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 27: USA 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 28: USA Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 29: USA 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

CANADA

Table 30: Canada Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 31: Canada 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 32: Canada Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 33: Canada 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

JAPAN

Table 34: Japan Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 35: Japan 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 36: Japan Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 37: Japan 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

CHINA

Table 38: China Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 39: China 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 40: China Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 41: China 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

EUROPE

ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 42: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 43: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
Table 44: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 45: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 46: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 47: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

FRANCE

Table 48: France Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 49: France 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 50: France Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 51: France 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

GERMANY

Table 52: Germany Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 53: Germany 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 54: Germany Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 55: Germany 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

ITALY

Table 56: Italy Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 57: Italy 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 58: Italy Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 59: Italy 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

UNITED KINGDOM

Table 60: UK Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 61: UK 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 62: UK Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 63: UK 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

REST OF EUROPE

Table 64: Rest of Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 65: Rest of Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 66: Rest of Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 67: Rest of Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

ASIA-PACIFIC

ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 68: Asia-Pacific Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 69: Asia-Pacific 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 70: Asia-Pacific Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 71: Asia-Pacific 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

REST OF WORLD

Table 72: Rest of World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 73: Rest of World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
Table 74: Rest of World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 75: Rest of World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION

Companies Mentioned

Anju Software, Inc.
ArisGlobal LLC
Castor EDC
Clario
Climedo Health GmbH
ClinCapture
Dassault Systèmes SE
eClinical Solutions LLC
ICON plc
IQVIA Holdings, Inc.
Kayentis, SAS
MedNet Solutions, Inc.
Signant Health
TransPerfect

Table Information

Report Attribute	Details
No. of Pages	411
Published	July 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 1.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.7 Billion
Compound Annual Growth Rate	15.0%
Regions Covered	Global
No. of Companies Mentioned	14

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4836EUR$4,950USD£4,038GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9189EUR$9,405USD£7,671GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14509EUR$14,850USD£12,113GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 85 Featured):

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

ePRO, E-patient Diaries and eCOA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Electronic Clinical Outcome Assessment (eCOA) Solution Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Use ([Clinical trial: Onco, Rare, Mental Health], RWE, Registery), End-user, and Region - Forecast to 2029

Electronic Clinical Outcome Assessment ECOA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, Safety), Deployment (On premise, Cloud), Application (Collection, Operations, Analytics), Trial Phase, End user (Pharma, Biotech, Med Devices), & Region - Global Forecast to 2029

Electronic Clinical Outcome Assessment Solutions Global Market Report 2024